I had a really interesting conversation today with my friend, Cheryl Landes. For those of you who don’t know Cheryl, she is a content organizer extraordinaire. Cheryl has tremendous experience – particularly in the indexing arena. And for those of you who don’t have an appreciation for the fine art
Content reuse is the practice of creating one piece of content and then using that piece of content everywhere you need it. A reused piece of content is created, finalized, translated, managed, stored, and retired one, and only one, time.
In pharmaceutical and biotech regulatory document development, your content strategy – the business plan for how you create, manage, and deliver content – significantly impacts your ability to innovate, comply with regulations, and ultimately, bring new medicines to market.
Our customers often face complex content problems that hinder their efficiency, scalability, and customer satisfaction. These challenges cost the enterprise money, time, and risk.
From 15 weeks to 10 minutes: Novo Nordisk now drafts clinical study reports with AI. Posts like this are common these days! What we don’t hear enough about is the rigorous planning and testing that goes into creating a controlled, repeatable solution. There was a lot of groundwork by the